Table 1.

Patients eligible for Delayed Primary Excision (DPE) at each primary tumor site. Alveolar rhabdomyosarcoma (ARMS), embryonal rhabdomyosarcoma (ERMS), parameningeal (PM)

Anatomic Site	Number Eligible For DPE	Number Undergoing DPE During Phase 1 of Therapy (percent)
I. ARMS, Group III, Head/Neck (non-orbital, non-PM) primaries, superficial sites, negative nodes	2	0 (0%)
II. ARMS, Group III, Vagina/Vulva/Uterus primaries, negative nodes	1	0 (0%)
III. ERMS or ARMS, Group III, Bladder Dome	24	12 (50%)
IV. ERMS or ARMS, Group III, Extremity	63	31 (49%)
V. ERMS or ARMS, Group III, Trunk/Retroperitoneum/Perineal/Perianal/Intra-thoracic/GI/Biliary	74	30 (41%)
Total	164	73 (45%)